ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

UHS vs EHC // EV/EBITDA & P/E VALUATION

Universal Health Services Inc. (NYSE) VS. Encompass Health Corporation (NYSE) • 15-METRIC TALLY: UHS 5 — EHC 7
▲ EV/EBITDA & P/E VALUATION LEADER: UHS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UHS VS. EHC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC UHS EHC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 14.10% 13.80% +0.30 UHS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 5.0x 15.8x -10.80 UHS /valuation <GO>
Free Cash Flow Yield 8.16% 2.92% +5.24 UHS /fcf-yield <GO>
Operating Margin 11.50% 11.60% -0.10 EHC /operating-margins <GO>
Net Profit Margin 8.60% 9.50% -0.90 EHC /net-margins <GO>
Revenue Growth (YoY) 9.70% 10.50% -0.80 EHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.49% 0.55% -0.06 EHC /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.11 3.47 -0.36 EHC /balance-sheet <GO>
Piotroski F-Score Quality 9/9 9/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 46.5 60.3 -13.80 EHC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 1.04 0.90 +0.14 UHS /macro-sensitivity <GO>
Forward P/E Multiple 6.5x 21.3x -14.80 UHS /forward-pe <GO>
Enterprise Scale & Market Cap $10.41B $12.97B -$2.56B EHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR UHS REV EHC REV UHS GROSS % EHC GROSS % UHS FCF EHC FCF
FY 2025 $17.36B $5.94B — — $849.2M —
FY 2024 $15.83B $5.37B — — $1.12B —
FY 2023 $14.28B $4.80B — — $625.1M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UHS // BETA 1.04
EHC // BETA 0.90